Education
About Us
Working with TipRanks
Follow Us
JD Health International, Inc. (HK:6618)
:6618
Earnings Data
Report Date
Aug 13, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
1.31Last Year’s EPS
0.92Same Quarter Last Year
Strong Buy
Based on 10 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a strongly positive operational and financial performance: double-digit revenue growth (26.3% YoY), materially higher non-IFRS profit growth (36.3% YoY), margin expansion, sizable user additions, heavy investment and traction in AI and product launches, and healthy operating cash flow. Challenges discussed were mostly execution and maturation-related (monetization of AI, rising S&M costs, offline economics, concentration of direct-sales revenue) rather than structural declines. On balance, the positive growth, margin improvements and strategic wins outweigh the cited risks and costs.Company Guidance
Strong Revenue Growth
Full-year 2025 revenue RMB 73.4 billion, up 26.3% year-over-year; Q4 2025 revenue RMB 21.0 billion, up 27.4% year-over-year; achieved >20% YoY revenue growth for four consecutive quarters.
Significant Profitability Improvement
Full-year non-IFRS profit RMB 6.5 billion, up 36.3% year-over-year with a non-IFRS profit margin of 8.9% (highest since IPO); Q4 non-IFRS profit RMB 1.1 billion, up 13.5% YoY with quarter margin of 5%.
Gross Margin Expansion
2025 gross margin 24.8%, up 1.9 percentage points year-over-year, reflecting benefits from direct sales and scale in the super pharmaceutical supply chain.
Direct Sales and Service Mix Strength
Direct sales revenue RMB 60.9 billion, up 24.8% YoY and representing 82.9% of total revenue; service revenue RMB 12.6 billion, up 34.1% YoY and representing 17.1% of total revenue (up 1 ppt).
User Base and Engagement Expansion
Annual active user accounts for the past 12 months ~220 million, net addition of 34 million vs Dec 31, 2024; AI agent Dr. Da Wei completed hundreds of millions of interactions with a reported 98% satisfaction rate.
Product Launch and Go-to-Market Wins
Introduced over 100 new drugs in 2025 (vs 30 in 2024); flagship launch DAYVIGO recorded >20,000 orders in launch month; premium fish oil launch generated ~15 billion impressions on launch date.
Service & Channel Expansion
Expanded online medical insurance payment coverage to 29 key cities; established >300 self-operated pharmacies nationwide; at-home rapid testing order volume increased 81.9% year-over-year.
AI and Clinical Deployments
Scaled AI and clinical solutions: JOY DOC served over 5 million patients across partnering hospitals; launched multiple AI products (AI Jingyi, JOY DOC, AI doctor digital twins) and AI-enabled device integrations (e.g., JD-branded continuous glucose monitor with Yuwell).
Healthy Operating Cash and Financial Income
Cash flow from operating activities RMB 10.2 billion; finance income RMB 1.5 billion in 2025; reported net increase in cash and equivalents and related assets (transcript-corrected figure noted as RMB 69.5 billion, net increase RMB 10.1 billion).
HK:6618 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HK:6618 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 05, 2026 | HK$50.65 | HK$47.50 | -6.22% |
Aug 14, 2025 | HK$55.95 | HK$54.85 | -1.97% |
Mar 06, 2025 | HK$38.65 | HK$40.80 | +5.56% |
Aug 15, 2024 | HK$20.45 | HK$19.82 | -3.08% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does JD Health International, Inc. (HK:6618) report earnings?
JD Health International, Inc. (HK:6618) is schdueled to report earning on Aug 13, 2026, TBA (Confirmed).
What is JD Health International, Inc. (HK:6618) earnings time?
JD Health International, Inc. (HK:6618) earnings time is at Aug 13, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of JD Health International, Inc. stock?
The P/E ratio of JD Health International, Inc. is N/A.
What is HK:6618 EPS forecast?
HK:6618 EPS forecast for the fiscal quarter 2026 (Q2) is 1.31.